Close

Hoth Therapeutics Inc. (HOTH) Begins First in Human Clinical Trial for the Treatment of Atopic Dermatitis with BioLexa

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/26/2024

1. META
2. CMG
3. LRCX
4. IBM
5. SPY
6. BA
7. HCP
8. SNAP
9. TMUS
10. MSFT


Go back to Hoth Therapeutics Inc. (HOTH) Begins First in Human Clinical Trial for the Treatment of Atopic Dermatitis with BioLexa
(NASDAQ: HOTH) Delayed: 1.17 --0 (-0%)
Previous Close $1.17    52 Week High $ 
Open $1.14    52 Week Low $ 
Day High $1.20    P/E N/A 
Day Low $1.10    EPS $ 
Volume 39,632